This was also in line with enhanced activation of the IFNα and IFNγ activation pathways, two cytokines with anti-tumor activity [32], in “CSPG4-high” tumors (respectively, p = 6.46 × 10−3 and p = 3.23 × 10−3). The gene discussed is IFNG; the disease is neoplasm.